UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

NOTICE OF EFFECTIVENESS

Effective Date:November 10, 2022
Accession Number:0001628280-22-029278
Submission Type:POS AM
CIK:0001842952
Company Name:Context Therapeutics Inc.
File Number:333-261599
Context Therapeutics (NASDAQ:CNTX)
Historical Stock Chart
From Feb 2024 to Mar 2024 Click Here for more Context Therapeutics Charts.
Context Therapeutics (NASDAQ:CNTX)
Historical Stock Chart
From Mar 2023 to Mar 2024 Click Here for more Context Therapeutics Charts.